The NJPMP is a statewide database that collects prescription data on Controlled Dangerous Substances (CDS), Human Growth Hormone and gabapentin dispensed in outpatient settings in New Jersey, and by out-of-state pharmacies dispensing in New Jersey. The New Jersey Prescription Monitoring Program (NJPMP) is an important component of the New Jersey Division of Consumer Affairs’ effort to halt the abuse and diversion of prescription drugs.
